Related Experiment Video
Updated: Aug 10, 2026
11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer
V Srikantan1, Z Zou, G Petrovics
1Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20814-4799, USA.
Summary
Researchers discovered PCGEM1, a prostate-specific noncoding RNA. This gene is overexpressed in prostate cancer tissues and linked to androgen receptor activity, suggesting a role in prostate cancer development.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Prostate cancer is a significant health concern.
- Identifying tissue-specific genes is crucial for understanding cancer biology.
- The role of noncoding RNAs in cancer is an emerging area of research.
Purpose of the Study:
- To identify and characterize PCGEM1, a novel gene expressed in prostate tissue.
- To investigate the expression patterns of PCGEM1 in normal and cancerous prostate tissues.
- To explore the potential function of PCGEM1 in prostate cancer development.
Main Methods:
- Differential display analysis of normal and prostate cancer tissues.
- Northern blot analysis for tissue-specific expression.
- In situ hybridization and reverse transcription-PCR for expression quantification.
- DNA sequencing and locus mapping.
Main Results:
- PCGEM1 is exclusively expressed in human prostate tissue.
- PCGEM1 is overexpressed in 84% of prostate tumors (in situ) and 56% (RT-PCR).
- PCGEM1 expression is detected in androgen receptor-positive LNCaP cells and is prostate-specific.
- PCGEM1 lacks protein-coding capacity, suggesting it is a noncoding RNA (riboregulator).
- PCGEM1 locus mapped to chromosome 2q32.
Conclusions:
- PCGEM1 exhibits prostate-tissue specificity and androgen-dependent expression.
- Elevated PCGEM1 expression in tumors suggests a role in prostate cancer biology and tumorigenesis.
- PCGEM1 represents a potential noncoding RNA biomarker or therapeutic target in prostate cancer.
Related Concept Videos
01:58Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...